Skip to main content
Erschienen in: World Journal of Surgery 4/2018

14.09.2017 | Scientific Review

Clinicopathological Risk Factors for Distant Metastasis in Differentiated Thyroid Carcinoma: A Meta-analysis

verfasst von: Huy Gia Vuong, Uyen N. P. Duong, Thong Quang Pham, Hung Minh Tran, Naoki Oishi, Kunio Mochizuki, Tadao Nakazawa, Lewis Hassell, Ryohei Katoh, Tetsuo Kondo

Erschienen in: World Journal of Surgery | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Distant metastasis (DM) is not a frequent event in differentiated thyroid carcinoma (DTC) but has an adverse impact on mortality of patients with DTC. In the current study, we aimed to conduct a comprehensive systematic review and meta-analysis to investigate the risk factors for DM in DTCs and for each histological subtype.

Methods

Five electronic databases were searched from inception to December 2016 for relevant articles. Pooled odd ratios and 95% confidence interval were calculated using random-effect model.

Results

Thirty-four articles with 73,219 patients were included for meta-analyses. In DTCs, male gender, age ≥45 years, tumor size ≥4 cm, multifocality, vascular invasion (VI), extrathyroidal extension (ETE), lymph node metastasis (LNM), and lateral LNM were demonstrated to be associated with significant risks for DM. In addition, several clinicopathological factors such as age ≥45 years, VI, ETE, and LNM were shown to be significant risk factors for DM in both PTC and FTC subgroups.

Conclusion

Our study demonstrated the promising value of several clinicopathological factors such as male gender, older age, VI, ETE, and LNM in predicting DM in PTCs and FTCs. Our study affirms the value of the selected clinicopathological factors for tumor risk stratification and assessment of patients’ prognosis.
Literatur
1.
Zurück zum Zitat Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140(4):317–322CrossRefPubMed Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140(4):317–322CrossRefPubMed
2.
Zurück zum Zitat De Lellis, Lloyd R, Heitz P, Eng C (2004) World Health Organization classification of tumours. In: De Lellis, Lloyd R, Heitz P, Eng C (eds) Pathology and genetics of tumours of endocrine organs. IARC Press, Lyon De Lellis, Lloyd R, Heitz P, Eng C (2004) World Health Organization classification of tumours. In: De Lellis, Lloyd R, Heitz P, Eng C (eds) Pathology and genetics of tumours of endocrine organs. IARC Press, Lyon
3.
Zurück zum Zitat LiVolsi V, Baloch Z (2002) Predicting prognosis in thyroid carcinoma: can histology do it? Am J Surg Pathol 26(8):1064–1065CrossRefPubMed LiVolsi V, Baloch Z (2002) Predicting prognosis in thyroid carcinoma: can histology do it? Am J Surg Pathol 26(8):1064–1065CrossRefPubMed
4.
Zurück zum Zitat LiVolsi VA (1996) Well differentiated thyroid carcinoma. Clin Oncol 8(5):281–288CrossRef LiVolsi VA (1996) Well differentiated thyroid carcinoma. Clin Oncol 8(5):281–288CrossRef
5.
Zurück zum Zitat Clark JR, Lai P, Hall F, Borglund A, Eski S, Freeman JL (2005) Variables predicting distant metastases in thyroid cancer. Laryngoscope 115(4):661–667CrossRefPubMed Clark JR, Lai P, Hall F, Borglund A, Eski S, Freeman JL (2005) Variables predicting distant metastases in thyroid cancer. Laryngoscope 115(4):661–667CrossRefPubMed
6.
Zurück zum Zitat Sugino K, Kameyama K, Ito K, Nagahama M, Kitagawa W, Shibuya H et al (2012) Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma. Thyroid 22(8):798–804CrossRefPubMed Sugino K, Kameyama K, Ito K, Nagahama M, Kitagawa W, Shibuya H et al (2012) Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma. Thyroid 22(8):798–804CrossRefPubMed
7.
Zurück zum Zitat Machens A, Holzhausen HJ, Lautenschlager C, Thanh PN, Dralle H (2003) Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma. Cancer 98(4):712–719CrossRefPubMed Machens A, Holzhausen HJ, Lautenschlager C, Thanh PN, Dralle H (2003) Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma. Cancer 98(4):712–719CrossRefPubMed
8.
Zurück zum Zitat Lin JD, Huang HS, Chen SC, Chao TC (1997) Factors that predict metastasis of papillary and follicular thyroid cancers in Taiwan. Otolaryngol Head Neck Surg 116(4):475–482CrossRefPubMed Lin JD, Huang HS, Chen SC, Chao TC (1997) Factors that predict metastasis of papillary and follicular thyroid cancers in Taiwan. Otolaryngol Head Neck Surg 116(4):475–482CrossRefPubMed
9.
Zurück zum Zitat Goffredo P, Sosa JA, Roman SA (2013) Differentiated thyroid cancer presenting with distant metastases: a population analysis over two decades. World J Surg 37(7):1599–1605CrossRefPubMed Goffredo P, Sosa JA, Roman SA (2013) Differentiated thyroid cancer presenting with distant metastases: a population analysis over two decades. World J Surg 37(7):1599–1605CrossRefPubMed
10.
Zurück zum Zitat Feinmesser M, Stern S, Mechlis-Frish S, Lubin E, Feinmesser R, Kristt D (1996) HLA-DR expression and lymphocytic infiltration in metastatic and non-metastatic papillary carcinoma of the thyroid. Eur J Surg Oncol 22(5):494–501CrossRefPubMed Feinmesser M, Stern S, Mechlis-Frish S, Lubin E, Feinmesser R, Kristt D (1996) HLA-DR expression and lymphocytic infiltration in metastatic and non-metastatic papillary carcinoma of the thyroid. Eur J Surg Oncol 22(5):494–501CrossRefPubMed
11.
Zurück zum Zitat Gandolfi G, Ragazzi M, Frasoldati A, Piana S, Ciarrocchi A, Sancisi V (2015) TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma. Eur J Endocrinol Eur Fed Endocr Soc 172(4):403–413CrossRef Gandolfi G, Ragazzi M, Frasoldati A, Piana S, Ciarrocchi A, Sancisi V (2015) TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma. Eur J Endocrinol Eur Fed Endocr Soc 172(4):403–413CrossRef
12.
Zurück zum Zitat Jeon MJ, Kim WG, Choi YM, Kwon H, Lee YM, Sung TY et al (2016) Features predictive of distant metastasis in papillary thyroid microcarcinomas. Thyroid 26(1):161–168CrossRefPubMed Jeon MJ, Kim WG, Choi YM, Kwon H, Lee YM, Sung TY et al (2016) Features predictive of distant metastasis in papillary thyroid microcarcinomas. Thyroid 26(1):161–168CrossRefPubMed
13.
Zurück zum Zitat Lin JD, Chao TC, Hsueh C (2004) Follicular thyroid carcinomas with lung metastases: a 23-year retrospective study. Endocr J 51(2):219–225CrossRefPubMed Lin JD, Chao TC, Hsueh C (2004) Follicular thyroid carcinomas with lung metastases: a 23-year retrospective study. Endocr J 51(2):219–225CrossRefPubMed
14.
Zurück zum Zitat Lin JD, Chao TC, Chou SC, Hsueh C (2004) Papillary thyroid carcinomas with lung metastases. Thyroid 14(12):1091–1096CrossRefPubMed Lin JD, Chao TC, Chou SC, Hsueh C (2004) Papillary thyroid carcinomas with lung metastases. Thyroid 14(12):1091–1096CrossRefPubMed
15.
Zurück zum Zitat Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K et al (2011) Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. Thyroid 21(7):751–757CrossRefPubMed Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K et al (2011) Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. Thyroid 21(7):751–757CrossRefPubMed
16.
Zurück zum Zitat Ito Y, Kihara M, Takamura Y, Kobayashi K, Miya A, Hirokawa M et al (2012) Prognosis and prognostic factors of papillary thyroid carcinoma in patients under 20 years. Endocr J 59(7):539–545CrossRefPubMed Ito Y, Kihara M, Takamura Y, Kobayashi K, Miya A, Hirokawa M et al (2012) Prognosis and prognostic factors of papillary thyroid carcinoma in patients under 20 years. Endocr J 59(7):539–545CrossRefPubMed
17.
Zurück zum Zitat Hoie J, Stenwig AE, Kullmann G, Lindegaard M (1988) Distant metastases in papillary thyroid cancer. A review of 91 patients. Cancer 61(1):1–6CrossRefPubMed Hoie J, Stenwig AE, Kullmann G, Lindegaard M (1988) Distant metastases in papillary thyroid cancer. A review of 91 patients. Cancer 61(1):1–6CrossRefPubMed
18.
Zurück zum Zitat Lee YS, Lim YS, Lee JC, Wang SG, Kim IJ, Son SM et al (2011) Clinical implications of bilateral lateral cervical lymph node metastasis in papillary thyroid cancer: a risk factor for lung metastasis. Ann Surg Oncol 18(12):3486–3492CrossRefPubMed Lee YS, Lim YS, Lee JC, Wang SG, Kim IJ, Son SM et al (2011) Clinical implications of bilateral lateral cervical lymph node metastasis in papillary thyroid cancer: a risk factor for lung metastasis. Ann Surg Oncol 18(12):3486–3492CrossRefPubMed
19.
Zurück zum Zitat O’Neill CJ, Vaughan L, Learoyd DL, Sidhu SB, Delbridge LW, Sywak MS (2011) Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. Eur J Surg Oncol 37(2):181–185CrossRefPubMed O’Neill CJ, Vaughan L, Learoyd DL, Sidhu SB, Delbridge LW, Sywak MS (2011) Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. Eur J Surg Oncol 37(2):181–185CrossRefPubMed
20.
Zurück zum Zitat Ban EJ, Andrabi A, Grodski S, Yeung M, McLean C, Serpell J (2012) Follicular thyroid cancer: minimally invasive tumours can give rise to metastases. ANZ J Surg 82(3):136–139CrossRefPubMed Ban EJ, Andrabi A, Grodski S, Yeung M, McLean C, Serpell J (2012) Follicular thyroid cancer: minimally invasive tumours can give rise to metastases. ANZ J Surg 82(3):136–139CrossRefPubMed
21.
Zurück zum Zitat Jang EK, Song DE, Sim SY, Kwon H, Choi YM, Jeon MJ et al (2014) NRAS codon 61 mutation is associated with distant metastasis in patients with follicular thyroid carcinoma. Thyroid 24(8):1275–1281CrossRefPubMedPubMedCentral Jang EK, Song DE, Sim SY, Kwon H, Choi YM, Jeon MJ et al (2014) NRAS codon 61 mutation is associated with distant metastasis in patients with follicular thyroid carcinoma. Thyroid 24(8):1275–1281CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Mai KT, Khanna P, Yazdi HM, Perkins DG, Veinot JP, Thomas J et al (2002) Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hurthle cell and papillary thyroid carcinoma. Pathology 34(3):239–244CrossRefPubMed Mai KT, Khanna P, Yazdi HM, Perkins DG, Veinot JP, Thomas J et al (2002) Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hurthle cell and papillary thyroid carcinoma. Pathology 34(3):239–244CrossRefPubMed
23.
Zurück zum Zitat O’Neill CJ, Vaughan L, Learoyd DL, Sidhu SB, Delbridge LW, Sywak MS (2011) Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. Eur J Surg Oncol 37(2):181–185CrossRefPubMed O’Neill CJ, Vaughan L, Learoyd DL, Sidhu SB, Delbridge LW, Sywak MS (2011) Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. Eur J Surg Oncol 37(2):181–185CrossRefPubMed
24.
Zurück zum Zitat Sancisi V, Nicoli D, Ragazzi M, Piana S, Ciarrocchi A (2012) BRAFV600E mutation does not mean distant metastasis in thyroid papillary carcinomas. J Clin Endocrinol Metab 97(9):E1745–E1749CrossRefPubMed Sancisi V, Nicoli D, Ragazzi M, Piana S, Ciarrocchi A (2012) BRAFV600E mutation does not mean distant metastasis in thyroid papillary carcinomas. J Clin Endocrinol Metab 97(9):E1745–E1749CrossRefPubMed
25.
Zurück zum Zitat Yamashita H, Noguchi S, Murakami N, Kawamoto H, Watanabe S (1997) Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma. Cancer 80(12):2268–2272CrossRefPubMed Yamashita H, Noguchi S, Murakami N, Kawamoto H, Watanabe S (1997) Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma. Cancer 80(12):2268–2272CrossRefPubMed
26.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRefPubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Borenstein M, Hedges LV, Higgins JP, Rothstein HR (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 1(2):97–111CrossRefPubMed Borenstein M, Hedges LV, Higgins JP, Rothstein HR (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 1(2):97–111CrossRefPubMed
29.
Zurück zum Zitat Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558CrossRefPubMed Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558CrossRefPubMed
32.
Zurück zum Zitat Farahati J, Bucsky P, Parlowsky T, Mader U, Reiners C (1997) Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology. Cancer 80(11):2156–2162CrossRefPubMed Farahati J, Bucsky P, Parlowsky T, Mader U, Reiners C (1997) Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology. Cancer 80(11):2156–2162CrossRefPubMed
33.
Zurück zum Zitat Garg A, Chopra S, Ballal S, Soundararajan R, Bal CS (2015) Differentiated thyroid cancer in patients over 60 years of age at presentation: a retrospective study of 438 patients. J Geriatr Oncol 6(1):29–37CrossRefPubMed Garg A, Chopra S, Ballal S, Soundararajan R, Bal CS (2015) Differentiated thyroid cancer in patients over 60 years of age at presentation: a retrospective study of 438 patients. J Geriatr Oncol 6(1):29–37CrossRefPubMed
34.
Zurück zum Zitat Ito Y, Masuoka H, Fukushima M, Inoue H, Kihara M, Tomoda C et al (2010) Prognosis and prognostic factors of patients with papillary carcinoma showing distant metastasis at surgery (M1 patients) in Japan. Endocr J 57(6):523–531CrossRefPubMed Ito Y, Masuoka H, Fukushima M, Inoue H, Kihara M, Tomoda C et al (2010) Prognosis and prognostic factors of patients with papillary carcinoma showing distant metastasis at surgery (M1 patients) in Japan. Endocr J 57(6):523–531CrossRefPubMed
35.
Zurück zum Zitat Jing F-j, Liang J, Z-y Liang, Meng C, Long W, X-y Li et al (2013) BRAF(v600E) mutation is not a positive predictor for distant metastasis in sporadic papillary thyroid carcinoma. Chin Med J (Engl) 126(16):3013–3018 Jing F-j, Liang J, Z-y Liang, Meng C, Long W, X-y Li et al (2013) BRAF(v600E) mutation is not a positive predictor for distant metastasis in sporadic papillary thyroid carcinoma. Chin Med J (Engl) 126(16):3013–3018
36.
Zurück zum Zitat Kremser R, Obrist P, Spizzo G, Erler H, Kendler D, Kemmler G et al (2003) Her2/neu overexpression in differentiated thyroid carcinomas predicts metastatic disease. Virchows Archiv Int J Pathol 442(4):322–328 Kremser R, Obrist P, Spizzo G, Erler H, Kendler D, Kemmler G et al (2003) Her2/neu overexpression in differentiated thyroid carcinomas predicts metastatic disease. Virchows Archiv Int J Pathol 442(4):322–328
37.
Zurück zum Zitat Kurt B, Yalcin S, Alagoz E, Karslioglu Y, Yigit N, Gunal A et al (2012) The relationship of the BRAF(V600E) mutation and the established prognostic factors in papillary thyroid carcinomas. Endocr Pathol 23(3):135–140CrossRefPubMed Kurt B, Yalcin S, Alagoz E, Karslioglu Y, Yigit N, Gunal A et al (2012) The relationship of the BRAF(V600E) mutation and the established prognostic factors in papillary thyroid carcinomas. Endocr Pathol 23(3):135–140CrossRefPubMed
38.
Zurück zum Zitat La Quaglia MP, Black T, Holcomb GW 3rd, Sklar C, Azizkhan RG, Haase GM et al (2000) Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children’s Cancer Group. J Pediatr Surg 35(6):955–959 (discussion 60) CrossRefPubMed La Quaglia MP, Black T, Holcomb GW 3rd, Sklar C, Azizkhan RG, Haase GM et al (2000) Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children’s Cancer Group. J Pediatr Surg 35(6):955–959 (discussion 60) CrossRefPubMed
39.
Zurück zum Zitat Lang BH, Shek TW, Wu AL, Wan KY (2017) The total number of tissue blocks per centimetre of tumor significantly correlated with the risk of distant metastasis in patients with minimally invasive follicular thyroid carcinoma. Endocrine 55(2):496–502CrossRefPubMed Lang BH, Shek TW, Wu AL, Wan KY (2017) The total number of tissue blocks per centimetre of tumor significantly correlated with the risk of distant metastasis in patients with minimally invasive follicular thyroid carcinoma. Endocrine 55(2):496–502CrossRefPubMed
40.
Zurück zum Zitat Lee YM, Song DE, Kim TY, Sung TY, Yoon JH, Chung KW et al (2016) Risk factors for distant metastasis in patients with minimally invasive follicular thyroid carcinoma. PLoS ONE 11(5):e0155489CrossRefPubMedPubMedCentral Lee YM, Song DE, Kim TY, Sung TY, Yoon JH, Chung KW et al (2016) Risk factors for distant metastasis in patients with minimally invasive follicular thyroid carcinoma. PLoS ONE 11(5):e0155489CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Li YR, Chen ST, Hseuh C, Chao TC, Ho TY, Lin JD (2015) Risk factors of distant metastasis in the follicular variant of papillary thyroid carcinoma. J Formos Med Assoc 115:665–671CrossRefPubMed Li YR, Chen ST, Hseuh C, Chao TC, Ho TY, Lin JD (2015) Risk factors of distant metastasis in the follicular variant of papillary thyroid carcinoma. J Formos Med Assoc 115:665–671CrossRefPubMed
42.
Zurück zum Zitat Scheumman GF, Hoang-Vu C, Cetin Y, Gimm O, Behrends J, von Wasielewski R et al (1995) Clinical significance of E-cadherin as a prognostic marker in thyroid carcinomas. J Clin Endocrinol Metab 80(7):2168–2172PubMed Scheumman GF, Hoang-Vu C, Cetin Y, Gimm O, Behrends J, von Wasielewski R et al (1995) Clinical significance of E-cadherin as a prognostic marker in thyroid carcinomas. J Clin Endocrinol Metab 80(7):2168–2172PubMed
43.
Zurück zum Zitat Spriano G, Ruscito P, Pellini R, Appetecchia M, Roselli R (2009) Pattern of regional metastases and prognostic factors in differentiated thyroid carcinoma. Acta Otorhinolaryngol Ital 29(6):312–316PubMedPubMedCentral Spriano G, Ruscito P, Pellini R, Appetecchia M, Roselli R (2009) Pattern of regional metastases and prognostic factors in differentiated thyroid carcinoma. Acta Otorhinolaryngol Ital 29(6):312–316PubMedPubMedCentral
44.
Zurück zum Zitat Sugino K, Kure Y, Iwasaki H, Ozaki O, Mimura T, Matsumoto A et al (1995) Metastases to the regional lymph nodes, lymph node recurrence, and distant metastases in nonadvanced papillary thyroid carcinoma. Surg Today 25(4):324–328CrossRefPubMed Sugino K, Kure Y, Iwasaki H, Ozaki O, Mimura T, Matsumoto A et al (1995) Metastases to the regional lymph nodes, lymph node recurrence, and distant metastases in nonadvanced papillary thyroid carcinoma. Surg Today 25(4):324–328CrossRefPubMed
45.
Zurück zum Zitat Verkooijen RB, Rietbergen D, Smit JW, Romijn JA, Stokkel MP (2007) A new functional parameter measured at the time of ablation that can be used to predict differentiated thyroid cancer recurrence during follow-up. Eur J Endocrinol 156(1):41–47CrossRefPubMed Verkooijen RB, Rietbergen D, Smit JW, Romijn JA, Stokkel MP (2007) A new functional parameter measured at the time of ablation that can be used to predict differentiated thyroid cancer recurrence during follow-up. Eur J Endocrinol 156(1):41–47CrossRefPubMed
46.
Zurück zum Zitat Welch Dinauer CA, Tuttle RM, Robie DK, McClellan DR, Svec RL, Adair C et al (1998) Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol (Oxf) 49(5):619–628CrossRef Welch Dinauer CA, Tuttle RM, Robie DK, McClellan DR, Svec RL, Adair C et al (1998) Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol (Oxf) 49(5):619–628CrossRef
47.
Zurück zum Zitat Yamashita H, Noguchi Y, Noguchi S, Yamashita H, Uchino S, Watanabe S et al (2005) Significance of an insular component in follicular thyroid carcinoma with distant metastasis at initial presentation. Endocr Pathol 16(1):41–48CrossRefPubMed Yamashita H, Noguchi Y, Noguchi S, Yamashita H, Uchino S, Watanabe S et al (2005) Significance of an insular component in follicular thyroid carcinoma with distant metastasis at initial presentation. Endocr Pathol 16(1):41–48CrossRefPubMed
48.
Zurück zum Zitat Vuong HG, Altibi AM, Abdelhamid AH, Ngoc PU, Quan VD, Tantawi MY et al (2017) The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review. Oncotarget 8(6):10637–10649CrossRefPubMed Vuong HG, Altibi AM, Abdelhamid AH, Ngoc PU, Quan VD, Tantawi MY et al (2017) The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review. Oncotarget 8(6):10637–10649CrossRefPubMed
49.
Zurück zum Zitat Cady B, Rossi R (1988) An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104(6):947–953PubMed Cady B, Rossi R (1988) An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104(6):947–953PubMed
50.
Zurück zum Zitat Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114(6):1050–1057 (discussion 7–8) PubMed Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114(6):1050–1057 (discussion 7–8) PubMed
51.
Zurück zum Zitat Guo K, Wang Z (2014) Risk factors influencing the recurrence of papillary thyroid carcinoma: a systematic review and meta-analysis. Int J Clin Exp Pathol 7(9):5393–5403PubMedPubMedCentral Guo K, Wang Z (2014) Risk factors influencing the recurrence of papillary thyroid carcinoma: a systematic review and meta-analysis. Int J Clin Exp Pathol 7(9):5393–5403PubMedPubMedCentral
52.
Zurück zum Zitat Sun W, Lan X, Zhang H, Dong W, Wang Z, He L et al (2015) Risk factors for central lymph node metastasis in CN0 papillary thyroid carcinoma: a systematic review and meta-analysis. PLoS ONE 10(10):e0139021CrossRefPubMedPubMedCentral Sun W, Lan X, Zhang H, Dong W, Wang Z, He L et al (2015) Risk factors for central lymph node metastasis in CN0 papillary thyroid carcinoma: a systematic review and meta-analysis. PLoS ONE 10(10):e0139021CrossRefPubMedPubMedCentral
53.
Zurück zum Zitat Qu H, Sun GR, Liu Y, He QS (2015) Clinical risk factors for central lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Clin Endocrinol (Oxf) 83(1):124–132CrossRef Qu H, Sun GR, Liu Y, He QS (2015) Clinical risk factors for central lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Clin Endocrinol (Oxf) 83(1):124–132CrossRef
54.
Zurück zum Zitat Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE et al (2016) 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133CrossRefPubMedPubMedCentral Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE et al (2016) 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133CrossRefPubMedPubMedCentral
55.
Zurück zum Zitat Vuong HG, Kondo T, Duong UNP, Pham TQ, Oishi N, Mochizuki K et al (2017) Prognostic impact of vascular invasion in differentiated thyroid carcinoma: a systematic review and meta-analysis. Eur J Endocrinol 177:207–216CrossRefPubMed Vuong HG, Kondo T, Duong UNP, Pham TQ, Oishi N, Mochizuki K et al (2017) Prognostic impact of vascular invasion in differentiated thyroid carcinoma: a systematic review and meta-analysis. Eur J Endocrinol 177:207–216CrossRefPubMed
56.
Zurück zum Zitat Sobrinho-Simoes M, Eloy C, Magalhaes J, Lobo C, Amaro T (2011) Follicular thyroid carcinoma. Mod Pathol 24:S10–S18CrossRefPubMed Sobrinho-Simoes M, Eloy C, Magalhaes J, Lobo C, Amaro T (2011) Follicular thyroid carcinoma. Mod Pathol 24:S10–S18CrossRefPubMed
57.
Zurück zum Zitat Barnabei A, Ferretti E, Baldelli R, Procaccini A, Spriano G, Appetecchia M (2009) Hurthle cell tumours of the thyroid. Personal experience and review of the literature. Acta Otorhinolaryngol Ital 29(6):305–311PubMedPubMedCentral Barnabei A, Ferretti E, Baldelli R, Procaccini A, Spriano G, Appetecchia M (2009) Hurthle cell tumours of the thyroid. Personal experience and review of the literature. Acta Otorhinolaryngol Ital 29(6):305–311PubMedPubMedCentral
58.
Zurück zum Zitat McDonald MP, Sanders LE, Silverman ML, Chan HS, Buyske J (1996) Hurthle cell carcinoma of the thyroid gland: prognostic factors and results of surgical treatment. Surgery 120(6):1000–1004 (discussion 4–5) CrossRefPubMed McDonald MP, Sanders LE, Silverman ML, Chan HS, Buyske J (1996) Hurthle cell carcinoma of the thyroid gland: prognostic factors and results of surgical treatment. Surgery 120(6):1000–1004 (discussion 4–5) CrossRefPubMed
59.
Zurück zum Zitat Shaha AR, Loree TR, Shah JP (1995) Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 118(6):1131–1136 (discussion 6–8) CrossRefPubMed Shaha AR, Loree TR, Shah JP (1995) Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 118(6):1131–1136 (discussion 6–8) CrossRefPubMed
Metadaten
Titel
Clinicopathological Risk Factors for Distant Metastasis in Differentiated Thyroid Carcinoma: A Meta-analysis
verfasst von
Huy Gia Vuong
Uyen N. P. Duong
Thong Quang Pham
Hung Minh Tran
Naoki Oishi
Kunio Mochizuki
Tadao Nakazawa
Lewis Hassell
Ryohei Katoh
Tetsuo Kondo
Publikationsdatum
14.09.2017
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 4/2018
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-017-4206-1

Weitere Artikel der Ausgabe 4/2018

World Journal of Surgery 4/2018 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.